De novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia

Berthony Deslouches, Ivan Gonzalez, Dilhari DeAlmeida, Kazi Islam, Chad Steele, Ronald C. Montelaro, Timothy A. Mietzner

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Objectives: We describe the antimicrobial activity against Pseudomonas aeruginosa of the de novo-derived antimicrobial peptide WLBU2 in an animal model of infection. Methods: For this study, an intravenous (iv)model of P. aeruginosa infection was established. The minimum lethal murine dose of P. aeruginosa strain PA01 was determined to be 3 × 107 cfu when bacteria were administered iv. Increasing concentrations of WLBU2 were instilled either prior to or following PA01 septic exposure. Results: For the mice given peptide post-bacterial infection, in the 1 mg/kg group, nine of nine animals died because of Pseudomonas sepsis; in the 3 mg/kg group, only one of nine succumbed to infection and in the 4 mg/kg group, all mice were protected (P < 0.0001). Similar results were obtained when WLBU2 was given 1 h prior to Pseudomonas infection. Conclusions: Although the therapeutic window in this model is narrow, the results nonetheless provide encouraging evidence for WLBU2 as a potential prophylactic or treatment of bacterial infection.

Original languageEnglish
Pages (from-to)669-672
Number of pages4
JournalJournal of Antimicrobial Chemotherapy
Volume60
Issue number3
DOIs
StatePublished - Sep 1 2007
Externally publishedYes

Fingerprint

Antimicrobial Cationic Peptides
Bacteremia
Pseudomonas aeruginosa
Pseudomonas Infections
Bacterial Infections
Pseudomonas
Infection
Sepsis
Animal Models
Bacteria
Peptides
Therapeutics

Keywords

  • Antimicrobial peptide
  • Sepsis
  • WLBU2

ASJC Scopus subject areas

  • Pharmacology
  • Microbiology

Cite this

De novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia. / Deslouches, Berthony; Gonzalez, Ivan; DeAlmeida, Dilhari; Islam, Kazi; Steele, Chad; Montelaro, Ronald C.; Mietzner, Timothy A.

In: Journal of Antimicrobial Chemotherapy, Vol. 60, No. 3, 01.09.2007, p. 669-672.

Research output: Contribution to journalArticle

Deslouches, Berthony ; Gonzalez, Ivan ; DeAlmeida, Dilhari ; Islam, Kazi ; Steele, Chad ; Montelaro, Ronald C. ; Mietzner, Timothy A. / De novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia. In: Journal of Antimicrobial Chemotherapy. 2007 ; Vol. 60, No. 3. pp. 669-672.
@article{a4837dae62f84a7faad65bcb2497a22b,
title = "De novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia",
abstract = "Objectives: We describe the antimicrobial activity against Pseudomonas aeruginosa of the de novo-derived antimicrobial peptide WLBU2 in an animal model of infection. Methods: For this study, an intravenous (iv)model of P. aeruginosa infection was established. The minimum lethal murine dose of P. aeruginosa strain PA01 was determined to be 3 × 107 cfu when bacteria were administered iv. Increasing concentrations of WLBU2 were instilled either prior to or following PA01 septic exposure. Results: For the mice given peptide post-bacterial infection, in the 1 mg/kg group, nine of nine animals died because of Pseudomonas sepsis; in the 3 mg/kg group, only one of nine succumbed to infection and in the 4 mg/kg group, all mice were protected (P < 0.0001). Similar results were obtained when WLBU2 was given 1 h prior to Pseudomonas infection. Conclusions: Although the therapeutic window in this model is narrow, the results nonetheless provide encouraging evidence for WLBU2 as a potential prophylactic or treatment of bacterial infection.",
keywords = "Antimicrobial peptide, Sepsis, WLBU2",
author = "Berthony Deslouches and Ivan Gonzalez and Dilhari DeAlmeida and Kazi Islam and Chad Steele and Montelaro, {Ronald C.} and Mietzner, {Timothy A.}",
year = "2007",
month = "9",
day = "1",
doi = "10.1093/jac/dkm253",
language = "English",
volume = "60",
pages = "669--672",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - De novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia

AU - Deslouches, Berthony

AU - Gonzalez, Ivan

AU - DeAlmeida, Dilhari

AU - Islam, Kazi

AU - Steele, Chad

AU - Montelaro, Ronald C.

AU - Mietzner, Timothy A.

PY - 2007/9/1

Y1 - 2007/9/1

N2 - Objectives: We describe the antimicrobial activity against Pseudomonas aeruginosa of the de novo-derived antimicrobial peptide WLBU2 in an animal model of infection. Methods: For this study, an intravenous (iv)model of P. aeruginosa infection was established. The minimum lethal murine dose of P. aeruginosa strain PA01 was determined to be 3 × 107 cfu when bacteria were administered iv. Increasing concentrations of WLBU2 were instilled either prior to or following PA01 septic exposure. Results: For the mice given peptide post-bacterial infection, in the 1 mg/kg group, nine of nine animals died because of Pseudomonas sepsis; in the 3 mg/kg group, only one of nine succumbed to infection and in the 4 mg/kg group, all mice were protected (P < 0.0001). Similar results were obtained when WLBU2 was given 1 h prior to Pseudomonas infection. Conclusions: Although the therapeutic window in this model is narrow, the results nonetheless provide encouraging evidence for WLBU2 as a potential prophylactic or treatment of bacterial infection.

AB - Objectives: We describe the antimicrobial activity against Pseudomonas aeruginosa of the de novo-derived antimicrobial peptide WLBU2 in an animal model of infection. Methods: For this study, an intravenous (iv)model of P. aeruginosa infection was established. The minimum lethal murine dose of P. aeruginosa strain PA01 was determined to be 3 × 107 cfu when bacteria were administered iv. Increasing concentrations of WLBU2 were instilled either prior to or following PA01 septic exposure. Results: For the mice given peptide post-bacterial infection, in the 1 mg/kg group, nine of nine animals died because of Pseudomonas sepsis; in the 3 mg/kg group, only one of nine succumbed to infection and in the 4 mg/kg group, all mice were protected (P < 0.0001). Similar results were obtained when WLBU2 was given 1 h prior to Pseudomonas infection. Conclusions: Although the therapeutic window in this model is narrow, the results nonetheless provide encouraging evidence for WLBU2 as a potential prophylactic or treatment of bacterial infection.

KW - Antimicrobial peptide

KW - Sepsis

KW - WLBU2

UR - http://www.scopus.com/inward/record.url?scp=34548138990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548138990&partnerID=8YFLogxK

U2 - 10.1093/jac/dkm253

DO - 10.1093/jac/dkm253

M3 - Article

C2 - 17623696

AN - SCOPUS:34548138990

VL - 60

SP - 669

EP - 672

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

SN - 0305-7453

IS - 3

ER -